Published in Managed Care Business Week, June 22nd, 2004
This extensive retrospective study of prescription drug pricing by the pharmaceutical manufacturers - price increases that ultimately tend to be passed on to drug purchasers - is the latest action in AARP's campaign for affordable drugs. The study is one of two new activities the Association unveiled that will closely monitor the pricing actions of the industry. The other is the "Rx Watchdog...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.